SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 428.40
arrow_upward
+1.42%(+6.00) 1D
10-р сарын 9, 17:29:43 (GMT+2) · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 427.60
High
SEK 431.60
Low
SEK 426.60
Mkt. cap
153.21Т
Avg. vol.
268.70 мян
Volume
179.02 мян
P/E ratio
114.42
52-wk high
SEK 487.00
52-wk low
SEK 293.60
EPS
SEK 3.74
Shares outstanding
357.64 сая
No. of employees
2 мян
Open
SEK 427.60
High
SEK 431.60
Low
SEK 426.60
Mkt. cap
153.21Т
Avg. vol.
268.70 мян
Volume
179.02 мян
P/E ratio
114.42
52-wk high
SEK 487.00
52-wk low
SEK 293.60
EPS
SEK 3.74
Shares outstanding
357.64 сая
No. of employees
2 мян
News stories
From web sources and news partners
TradingView
·
47 минутын өмнө
Key facts: NASDAQ:SPCX to buy 800MHz spectrum; developing non‑GEO D2D
MarketBeat
·
1 цагийн өмнө
LegalZoom.com, Inc. (NASDAQ:LZ) Stock Has Consensus Price Target of $7.30
Simply Wall Street
·
1 цагийн өмнө
ASML (NasdaqGS:ASML) Stock Could Be Fully Valued As AI Demand Builds
Yahoo Finance
·
9 цагийн өмнө
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)